SmartKem, Inc. entered into Amendment No. 1 to its March 30, 2026, Securities Purchase Agreement to allow a new party to join the group of institutional investors and to reallocate the number of Series A convertible preferred stock and warrants available for purchase. This amendment does not change the aggregate $17,129,200.00 maximum purchase amount. The company previously completed an additional closing on June 22, 2026, and another on July 16, 2026, involving the sale of Series A Preferred Stock and warrants for approximately $4.0 million and $1.0 million respectively. SmartKem, Inc. is a company that develops and markets skincare products.